On Sept. 24, after a year highlighted by so many virtual events, the Class of 2024 finally celebrated their medical school journey with a White Coat Ceremony – hosted in-person.
The pathogen listeria soon may become easier to track down in food recalls, thanks to a new genomic and geological mapping tool created by Cornell food scientists.
Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a new study has uncovered a way to counter this effect.
Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Paula Cohen, associate vice provost for life sciences, is leading an eight-year, $8 million, multi-institution grant to untangle the complex genetic rulebook for how sperm develops.
A Baker Institute for Animal Health study finds the antimicrobial properties of certain stem cell proteins could help treat skin infections that are resistant to antibiotics.
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
A Cornell-led COVID-19 patient registry, organized by Weill Cornell Medicine, continues to be a source of medical insight into the workings of the novel coronavirus and treatment of infected patients.